73 related articles for article (PubMed ID: 17111081)
1. Usefulness of an immunochromatographical assay, PSA Rapid Test as a primary screening test for prostate cancer.
Shigeno K; Arichi N; Yoneda T; Kishi H; Shiina H; Igawa M
Int Urol Nephrol; 2006; 38(3-4):565-9. PubMed ID: 17111081
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a rapid one-step PSA test for primary prostate cancer screening.
Ashida S; Yamasaki I; Kawada C; Fukuhara H; Fukata S; Tamura K; Karashima T; Inoue K; Shuin T
BMC Urol; 2021 Sep; 21(1):135. PubMed ID: 34579701
[TBL] [Abstract][Full Text] [Related]
3. Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL.
Faria EF; Carvalhal GF; dos Reis RB; Tobias-Machado M; Vieira RA; Reis LO; Nogueira L; Machado RD; Freitas CH; Magnabosco WJ; Mauad EC; Carvalho AL
BJU Int; 2012 Dec; 110(11 Pt B):E653-7. PubMed ID: 22892057
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of prostate-specific antigen (PSA) rise as a marker of prostate cancer in men treated with dutasteride: lessons from the REDUCE study.
Marberger M; Freedland SJ; Andriole GL; Emberton M; Pettaway C; Montorsi F; Teloken C; Rittmaster RS; Somerville MC; Castro R
BJU Int; 2012 Apr; 109(8):1162-9. PubMed ID: 21699645
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements.
Catalona WJ; Smith DS; Ornstein DK
JAMA; 1997 May; 277(18):1452-5. PubMed ID: 9145717
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of prostate cancer in aging males receiving PSA (prostate specific antigen) screening test (A campaign for celebration of Siriraj Established Day).
Srinualnad S; Charoenkraikamol C; Toraksa S; Uiprasertkul M; Amornvesukit T; Taweemonkongsap T; Udompunturak S; Nualyong C; Tantiwong A
J Med Assoc Thai; 2006 Jan; 89(1):37-42. PubMed ID: 16583579
[TBL] [Abstract][Full Text] [Related]
7. Comparison of different prostate-specific antigen cutpoints for early detection of prostate cancer: results of a large screening study.
Reissigl A; Pointner J; Horninger W; Ennemoser O; Strasser H; Klocker H; Bartsch G
Urology; 1995 Nov; 46(5):662-5. PubMed ID: 7495117
[TBL] [Abstract][Full Text] [Related]
8. Prostate-specific antigen assay using whole blood samples spotted on filter paper and its application to mass screening for prostate cancer.
Nanri M; Nanri K; Fujiyama C; Tokuda Y; Nakamura K; Uozumi J
Int J Urol; 2007 Jun; 14(6):505-9. PubMed ID: 17593094
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a new, rapid, qualitative, one-step PSA Test for prostate cancer screening: the PSA RapidScreen test.
Miano R; Mele GO; Germani S; Bove P; Sansalone S; Pugliese PF; Micali F
Prostate Cancer Prostatic Dis; 2005; 8(3):219-23. PubMed ID: 15897915
[TBL] [Abstract][Full Text] [Related]
10. Mass screening for prostate cancer in patients with end-stage renal disease: a comparative study.
Wada Y; Nakanishi J; Takahashi W; Kai N; Nakayama Y; Yamashita Y; Honda J; Ueda S
BJU Int; 2006 Oct; 98(4):794-7. PubMed ID: 16978274
[TBL] [Abstract][Full Text] [Related]
11. Long-term prostate-specific antigen contamination in the Spanish arm of the European Randomized Study of Screening for Prostate Cancer (ERSPC).
Luján M; Páez Á; Angulo JC; Granados R; Nevado M; Torres GM; Berenguer A
Actas Urol Esp; 2016 Apr; 40(3):164-72. PubMed ID: 26620123
[TBL] [Abstract][Full Text] [Related]
12. First year of mass screening for prostatic cancer in Yaizu city.
Kawabe K; Ishikawa A
Aktuelle Urol; 2003 Jul; 34(4):242-3. PubMed ID: 14566673
[TBL] [Abstract][Full Text] [Related]
13. Value of prostate-specific antigen (PSA) mass ratio in the detection of prostate cancer in men with PSA levels of ≤10 ng/mL.
Hong SK; Oh JJ; Byun SS; Hwang SI; Choo MS; Lee SE
BJU Int; 2012 Jul; 110(2 Pt 2):E81-5. PubMed ID: 22093144
[TBL] [Abstract][Full Text] [Related]
14. Screening for prostate cancer using prostate-specific antigen testing in Japanese men on hemodialysis.
Kurahashi T; Miyake H; Shinozaki M; Oka N; Takenaka A; Hara I; Matsumura Y; Fujisawa M
Int Urol Nephrol; 2008; 40(2):345-9. PubMed ID: 17619159
[TBL] [Abstract][Full Text] [Related]
15. Population-based screening for prostate cancer by measuring total serum prostate-specific antigen in Iran.
Hosseini SY; Moharramzadeh M; Ghadian AR; Hooshyar H; Lashay AR; Safarinejad MR
Int J Urol; 2007 May; 14(5):406-11. PubMed ID: 17511722
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer detection at low prostate specific antigen.
Schröder FH; van der Cruijsen-Koeter I; de Koning HJ; Vis AN; Hoedemaeker RF; Kranse R
J Urol; 2000 Mar; 163(3):806-12. PubMed ID: 10687982
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a rapid quantitative determination method of PSA concentration with gold immunochromatographic strips.
Wu CC; Lin HY; Wang CP; Lu LF; Yu TH; Hung WC; Houng JY; Chung FM; Lee YJ; Hu JJ
BMC Urol; 2015 Nov; 15():109. PubMed ID: 26530738
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance of malignant prostatic cells detection in blood for early detection of prostate cancer: comparison to prostatic biopsy.
Murray NP; Reyes E; Tapia P; Orellana N; Dueñas R; Fuentealba C; Badinez L
Arch Esp Urol; 2011 Dec; 64(10):961-71. PubMed ID: 22228894
[TBL] [Abstract][Full Text] [Related]
19. A performance analysis of the presence of malignant circulating prostate cells as a predictive factor for the detection of prostate cancer in the first, second and third prostate biopsy.
Murray NP; Reyes E; Tapia P; Badinez L; Orellana N; Fuentealba C; Olivares R; Dueñas R
Arch Esp Urol; 2013 May; 66(4):335-41. PubMed ID: 23676536
[TBL] [Abstract][Full Text] [Related]
20. [Clinical value of prostate specific antigen screening in early detection of prostate cancer].
Hua LX; Qiao D; Song NH; Feng NH; Yang J; Zhang JX; Chen JG; Zhang W; Sui YG; Wu HF
Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):705-9. PubMed ID: 20021870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]